Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the business’s stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $8.47, for a total value of $18,693.29. Following the completion of the transaction, the director now owns 28,826 shares in the […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the firm’s stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $8.47, for a total transaction of $18,693.29. Following the completion of the transaction, the director now owns 28,826 shares in the […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the firm’s stock in a transaction dated Thursday, July 6th. The shares were sold at an average price of $8.47, for a total value of $18,693.29. Following the sale, the director now directly owns 28,826 shares in the company, valued […]
Opaleye Management Inc. bought a new position in Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm bought 272,200 shares of the company’s stock, valued at approximately $2,613,000. Other institutional investors also recently bought and sold shares of the company. UBS Group AG grew its stake in shares […]
Millennium Management LLC decreased its holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Rating) by 36.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 257,621 shares of the company’s stock after selling 147,151 shares during the period. Millennium Management LLC owned about 0.99% […]